Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
35
days
Screening on the Paretic Side is Superior for Detecting Possible Sarcopenia in Individuals After Chronic Stroke: Preliminary Findings
Authors
Ana Luiza M. de Oliveira; Ana Carolina J. Galvão; Maria Clara F. de Oliveira; Lavínia P. dos Santos; Amanda A. O. Leopoldino; Janaine C. PoleseShow moreShow less
Affiliations
1. Department of Physical Therapy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; 2. Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, BrazilShow moreShow less
94
days
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study
Authors
Jialin Chen; Hongxi Chen; Xianglin Chu; Jie Song; Nana Zhang; Huahua Zhong; Zhangyu Zou; Hui Wu; Liewen Pang; Chongbo Zhao; Hongyu Zhou; Zhitao Gu; Sushan LuoShow moreShow less
Affiliations
1. Huashan Rare Disease Center & Department of Neurology, Huashan Hospital, Shanghai Medical College, National Center for Neurological Disorders, Fudan University, Shanghai, China; 2. Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China; 3. Department of Neurology, West China Hospital, Sichuan University, Chengdu, China; 4. Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China; 5. Department of Neurology, Jing’an District Centre Hospital of Shanghai, Shanghai, China; 6. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
48
days
Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks
Authors
Nina Sharp; Mahya Fani; Todd J. SchwedtShow moreShow less
Affiliations
1. The Design School, Arizona State University, Tempe, USA; 2. Department of Neurology, Mayo Clinic Arizona, Phoenix, USAShow moreShow less
41
days
Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial
Authors
Pavel Šiarnik; Žofia Rádiková; Branislav Kollár; Miroslava Kutšálová; Adela Penesová; Andrea Havranová; Richard Imrich; Miroslav Vlček; Ingrid Žitňanová; Georgi Krastev; Peter TurčániShow moreShow less
Affiliations
1. 1st Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia; 2. Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; 3. Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovakia; 4. Department of Neurology, Faculty Hospital, Trnava, SlovakiaShow moreShow less
47
days
ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different Algorithms
Authors
Barbara Poletti; Edoardo N. Aiello; Monica Consonni; Barbara Iazzolino; Silvia Torre; Veronica Faltracco; Alessandra Telesca; Francesca Palumbo; Beatrice Curti; Giulia De Luca; Arianna Moreschi; Francesca Frisco; Eleonora Dalla Bella; Enrica Bersano; Nilo Riva; Federico Verde; Stefano Messina; Alberto Doretti; Alessio Maranzano; Claudia Morelli; Stefano F. Cappa; Andrea Calvo; Michael J. Strong; Vincenzo Silani; Giuseppe Lauria; Adriano Chiò; Nicola TicozziShow moreShow less
Affiliations
1. Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy; 2. Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; 3. 3rd Neurology Unit and Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 4. “Rita Levi Montalcini”, Department of Neuroscience, Amyotrophic Lateral Sclerosis Center, University of Turin, Turin, Italy; 5. Neuroalgology Unit, Department of Clinical Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 6. Neurointensive Care Unit, Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 7. Department of Medical Biotechnology and Translational Medicine, Università Degli Studi Di Milano, Milan, Italy; 8. Neurology 1, City of Health and Science University Hospital of Turin, Turin, Italy; 9. Molecular Medicine Group, Schulich School of Medicine and Dentistry, Robarts Research Institute, Western University, London, Canada; 10. Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Canada; 11. Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Canada; 12. Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan, Italy; 13. Institute of Cognitive Science and Technologies, National Research Council, Rome, ItalyShow moreShow less
63
days
Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: The ORCHESTRA Study
Authors
Tobias Warnecke; Anton Adriaan Van der Plas; Petra Schwingenschuh; Anders Johansson; Mihaela Simu; Marie O’Meara; Resmi Gupta; Bjoern Fritz; Lars Bergmann; Juan Carlos Parra; Martin SüdmeyerShow moreShow less
Affiliations
1. Department of Neurology and Neurorehabilitation, Klinikum Osnabrück-Academic Teaching Hospital of the University of Münster, Osnabrück, Germany; 2. Alrijne Hospital Leiderdorp, Leiderdorp, Netherlands; 3. Department of Neurology, Medical University of Graz, Graz, Austria; 4. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 5. Department of Neurology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania; 6. AbbVie Inc., North Chicago, USA; 7. Department of Neurology, Klinikum Ernst Von Bergmann, Potsdam, Germany; 8. Department of Neurology, University Hospital Düsseldorf, Düsseldorf, GermanyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days